{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T01:12:28Z","timestamp":1785805948812,"version":"3.56.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.prp.2023.154425","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T20:02:48Z","timestamp":1679688168000},"page":"154425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["STAT3 signaling in pancreatic ductal adenocarcinoma: a candidate therapeutic target"],"prefix":"10.1016","volume":"245","author":[{"given":"Hussein Riyadh Abdul Kareem","family":"Al-Hetty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sada Jasim","family":"Abdulameer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami Awad","family":"Alkubaisy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawsan Ali","family":"Zaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abduladheem Turki","family":"Jalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihsan Khudhair","family":"Jasim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2023.154425_bib1","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nrc906","article-title":"Transcription factors as targets for cancer therapy","volume":"2","author":"Darnell","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2023.154425_bib2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.5483\/BMBRep.2019.52.7.152","article-title":"Highlighted STAT3 as a potential drug target for cancer therapy","volume":"52","author":"Lee","year":"2019","journal-title":"BMB Rep."},{"key":"10.1016\/j.prp.2023.154425_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12032-022-01908-4","article-title":"Role of STING protein in breast cancer: mechanisms and therapeutic implications","volume":"40","author":"Jiang","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.prp.2023.154425_bib4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41568-018-0090-8","article-title":"Therapeutically exploiting STAT3 activity in cancer\u2014using tissue repair as a road map","volume":"19","author":"Huynh","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2023.154425_bib5","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.ijbiomac.2018.05.121","article-title":"STAT3 and apoptosis challenges in cancer","volume":"117","author":"Fathi","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2023.154425_bib6","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1007\/s13277-015-4372-4","article-title":"IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer","volume":"37","author":"Wu","year":"2016","journal-title":"Tumor Biol."},{"key":"10.1016\/j.prp.2023.154425_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-020-01258-7","article-title":"Targeting STAT3 in cancer immunotherapy","volume":"19","author":"Zou","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2023.154425_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41575-020-00410-4","article-title":"The war against pancreatic cancer in 2020\u2014Advances on all fronts","volume":"18","author":"Jain","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.prp.2023.154425_bib9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3748\/wjg.v21.i1.262","article-title":"Long-term survival after resection of pancreatic cancer: a single-center retrospective analysis","volume":"21","author":"Yamamoto","year":"2015","journal-title":"World J. Gastroenterol.: WJG"},{"issue":"1","key":"10.1016\/j.prp.2023.154425_bib10","first-page":"36","article-title":"Correlation of N-terminal fragments of Atrial Natriuretic Neuropeptides (NT-ProANP) with Left Ventricle Ejection Fraction in Cases with Acute Myocardial Infarction","volume":"2","author":"Al-Athari","year":"2023","journal-title":"Journal of Biomedicine and Biochemistry"},{"key":"10.1016\/j.prp.2023.154425_bib11","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: a Cancer J. Clin."},{"key":"10.1016\/j.prp.2023.154425_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/MPA.0000000000000392","article-title":"Risk factors for early-onset and very-early-onset pancreatic adenocarcinoma: a pancreatic cancer case-control consortium (PanC4) analysis","volume":"45","author":"McWilliams","year":"2016","journal-title":"Pancreas"},{"key":"10.1016\/j.prp.2023.154425_bib13","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3945\/ajcn.113.058123","article-title":"Lifetime adiposity and risk of pancreatic cancer in the NIH-AARP diet and health study cohort","volume":"98","author":"Stolzenberg-Solomon","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.prp.2023.154425_bib14","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/jama.1995.03520440059037","article-title":"Diabetes mellitus as a risk factor for pancreatic cancer: a meta-analysis","volume":"273","author":"Everhart","year":"1995","journal-title":"Jama"},{"key":"10.1016\/j.prp.2023.154425_bib15","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S2468-1253(19)30416-9","article-title":"Early detection of pancreatic cancer","volume":"5","author":"Pereira","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.prp.2023.154425_bib16","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.pan.2012.06.002","article-title":"The burning question: why is smoking a risk factor for pancreatic cancer?","volume":"12","author":"Pandol","year":"2012","journal-title":"Pancreatology"},{"key":"10.1016\/j.prp.2023.154425_bib17","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s10654-019-00559-6","article-title":"Healthy lifestyle and the risk of pancreatic cancer in the EPIC study","volume":"35","author":"Naudin","year":"2020","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.prp.2023.154425_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/jmedgenet-2012-101277","article-title":"Pancreatic cancer risk in Peutz-Jeghers syndrome patients: a large cohort study and implications for surveillance","volume":"50","author":"Korsse","year":"2013","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.prp.2023.154425_bib19","unstructured":"Petrucelli N., Daly M.B., Pal T. BRCA1-and BRCA2-associated hereditary breast and ovarian cancer. 2016."},{"key":"10.1016\/j.prp.2023.154425_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00006676-199103000-00001","article-title":"Pancreatic cancer and the familial atypical multiple mole melanoma (FAMMM) syndrome","volume":"6","author":"Lynch","year":"1991","journal-title":"Pancreas"},{"key":"10.1016\/j.prp.2023.154425_bib21","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/ajg.2017.218","article-title":"Chronic pancreatitis and pancreatic cancer risk: a systematic review and meta-analysis","volume":"112","author":"Kirkeg\u00e5rd","year":"2017","journal-title":"Off. J. Am. Coll. Gastroenterol. | ACG"},{"key":"10.1016\/j.prp.2023.154425_bib22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4103\/1947-2714.157477","article-title":"Intraductal papillary mucinous neoplasm of pancreas","volume":"7","author":"Machado","year":"2015","journal-title":"North Am. J. Med. Sci."},{"key":"10.1016\/j.prp.2023.154425_bib23","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1053\/j.gastro.2013.01.071","article-title":"Roles for KRAS in pancreatic tumor development and progression","volume":"144","author":"Di Magliano","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prp.2023.154425_bib24","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0002-9440(10)64432-X","article-title":"Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia","volume":"161","author":"Van Heek","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2023.154425_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/cancers9050042","article-title":"KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 mutations in pancreatic cancer","volume":"9","author":"Cicenas","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2023.154425_bib26","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0092-8674(89)90438-8","article-title":"Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130","volume":"58","author":"Taga","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.prp.2023.154425_bib27","first-page":"945","article-title":"Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention","volume":"8","author":"Buettner","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2023.154425_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2008.04.049","article-title":"Crystal structure of unphosphorylated STAT3 core fragment","volume":"374","author":"Ren","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2023.154425_bib29","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.febslet.2013.01.065","article-title":"Observation of unphosphorylated STAT3 core protein binding to target dsDNA by PEMSA and X-ray crystallography","volume":"587","author":"Nkansah","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.prp.2023.154425_bib30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/28101","article-title":"Three-dimensional structure of the Stat3\u03b2 homodimer bound to DNA","volume":"394","author":"Becker","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.prp.2023.154425_bib31","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1021\/bi501529x","article-title":"Molecular determinants for unphosphorylated STAT3 dimerization determined by integrative modeling","volume":"54","author":"Sgrignani","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.prp.2023.154425_bib32","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2023.154425_bib33","doi-asserted-by":"crossref","DOI":"10.4161\/jkst.23010","article-title":"STAT3 activation: a key factor in tumor immunoescape","volume":"2","author":"R\u00e9b\u00e9","year":"2013","journal-title":"Jak. -Stat."},{"key":"10.1016\/j.prp.2023.154425_bib34","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.3390\/cancers11111728","article-title":"TYK2: an upstream kinase of STATs in cancer","volume":"11","author":"W\u00f6ss","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2023.154425_bib35","doi-asserted-by":"crossref","first-page":"12395","DOI":"10.1074\/jbc.M010715200","article-title":"Co-operative effect of c-Src tyrosine kinase and Stat3 in activation of hepatocyte growth factor expression in mammary carcinoma cells","volume":"276","author":"Hung","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2023.154425_bib36","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0092-8674(00)81443-9","article-title":"Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA","volume":"93","author":"Chen","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.prp.2023.154425_bib37","first-page":"1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.prp.2023.154425_bib38","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/cr.2008.41","article-title":"Roles of unphosphorylated STATs in signaling","volume":"18","author":"Yang","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.prp.2023.154425_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-021-01214-y","article-title":"STAT proteins: a kaleidoscope of canonical and non-canonical functions in immunity and cancer","volume":"14","author":"Awasthi","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.prp.2023.154425_bib40","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003236","article-title":"Oncogenes and tumor suppressor genes","volume":"2","author":"Lee","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.prp.2023.154425_bib41","doi-asserted-by":"crossref","DOI":"10.4161\/jkst.24716","article-title":"How should we define STAT3 as an oncogene and as a potential target for therapy?","volume":"2","author":"Sellier","year":"2013","journal-title":"Jak. -Stat."},{"key":"10.1016\/j.prp.2023.154425_bib42","doi-asserted-by":"crossref","first-page":"13060","DOI":"10.18632\/oncotarget.23962","article-title":"Meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with breast cancer","volume":"9","author":"Liu","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2023.154425_bib43","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1073\/pnas.97.8.4227","article-title":"Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo","volume":"97","author":"Grandis","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.prp.2023.154425_bib44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-8674(00)81959-5","article-title":"Stat3 as an oncogene","volume":"98","author":"Bromberg","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.prp.2023.154425_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-014-0924-5","article-title":"STAT3 Tyr705 phosphorylation affects clinical outcome in patients with newly diagnosed supratentorial glioblastoma","volume":"31","author":"Lin","year":"2014","journal-title":"Med. Oncol."},{"key":"10.1016\/j.prp.2023.154425_bib46","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.7150\/jca.47816","article-title":"Plasma soluble PD-L1 and STAT3 predict the prognosis in diffuse large B cell lymphoma patients","volume":"11","author":"Fei","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.prp.2023.154425_bib47","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neo.2015.01.003","article-title":"JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth","volume":"17","author":"Sen","year":"2015","journal-title":"Neoplasia"},{"key":"10.1016\/j.prp.2023.154425_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-09784-9","article-title":"LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2\/STAT3 signaling","volume":"10","author":"Luo","year":"2019","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.prp.2023.154425_bib49","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3390\/molecules28020841","article-title":"Management of Brain Cancer and Neurodegenerative Disorders with Polymer-Based Nanoparticles as a Biocompatible Platform","volume":"28","author":"Bazi Alahri","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.prp.2023.154425_bib50","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s12253-016-0134-x","article-title":"Clinical roles of interleukin-6 and STAT3 in oral squamous cell carcinoma","volume":"23","author":"Shinagawa","year":"2017","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.prp.2023.154425_bib51","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1158\/1078-0432.CCR-09-2658","article-title":"Nuclear localization of signal transducer and activator of transcription 3 in head and neck squamous cell carcinoma is associated with a better prognosisSTAT3 and prognosis in HNSCC","volume":"16","author":"Pectasides","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2023.154425_bib52","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s12094-012-0789-z","article-title":"Tissue microarray-based study of patients with lymph node-positive breast cancer shows tyrosine phosphorylation of signal transducer and activator of transcription 3 (tyrosine705-STAT3) is a marker of good prognosis","volume":"14","author":"A, Shriki","year":"2012","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.prp.2023.154425_bib53","first-page":"1","article-title":"STAT3 regulated ARF expression suppresses prostate cancer metastasis","volume":"6","author":"Pencik","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2023.154425_bib54","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/1947601913479022","article-title":"Cyclins and cell cycle control in cancer and disease","volume":"3","author":"Casimiro","year":"2012","journal-title":"Genes Cancer"},{"key":"10.1016\/j.prp.2023.154425_bib55","first-page":"5671","article-title":"Constitutive activation of STAT3 and cyclin D1 overexpression contribute to proliferation, migration and invasion in gastric cancer cells","volume":"9","author":"Luo","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.prp.2023.154425_bib56","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3390\/ijms19020448","article-title":"Apoptosis: a target for anticancer therapy","volume":"19","author":"Pfeffer","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2023.154425_bib57","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1074-7613(00)80011-4","article-title":"Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells","volume":"10","author":"Catlett-Falcone","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.prp.2023.154425_bib58","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.phymed.2018.09.180","article-title":"JAK2 regulation by licochalcone H inhibits the cell growth and induces apoptosis in oral squamous cell carcinoma","volume":"52","author":"Oh","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.prp.2023.154425_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-02907-6","article-title":"Xi Yu C, et al. VEGF-A stimulates STAT3 activity via nitrosylation of myocardin to regulate the expression of vascular smooth muscle cell differentiation markers","volume":"7","author":"Liao","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2023.154425_bib60","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.onc.1205260","article-title":"Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis","volume":"21","author":"Niu","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2023.154425_bib61","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920965853","article-title":"Hypo-fractionation radiotherapy normalizes tumor vasculature in non-small cell lung cancer xenografts through the p-STAT3\/HIF-1 alpha signaling pathway","volume":"12","author":"Tong","year":"2020","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.prp.2023.154425_bib62","first-page":"1","article-title":"Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3\/HIF-1\u03b1\/VEGF signalling","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2023.154425_bib63","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3389\/fonc.2019.01370","article-title":"Role of matrix metalloproteinases in angiogenesis and cancer","volume":"9","author":"Quintero-Fabi\u00e1n","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2023.154425_bib64","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1158\/1541-7786.MCR-17-0188","article-title":"ADAM12 is a novel regulator of tumor angiogenesis via STAT3 signalingtumor angiogenesis is regulated by ADAM12","volume":"15","author":"Roy","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.prp.2023.154425_bib65","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1007\/s002800051097","article-title":"Matrix metalloproteinases and metastasis","volume":"43","author":"Kleiner","year":"1999","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.prp.2023.154425_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-020-2627-5","article-title":"The interaction of interleukin-8 and PTEN inactivation promotes the malignant progression of head and neck squamous cell carcinoma via the STAT3 pathway","volume":"11","author":"Xu","year":"2020","journal-title":"Cell death Dis."},{"key":"10.1016\/j.prp.2023.154425_bib67","first-page":"1","article-title":"Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer","volume":"6","author":"Wu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.prp.2023.154425_bib68","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0304-3835(03)00482-8","article-title":"Blockade of constitutively activated Janus kinase\/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer","volume":"201","author":"Toyonaga","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2023.154425_bib69","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.bbrc.2005.06.162","article-title":"The transcription factor Stat3 is dispensable for pancreatic \u03b2-cell development and function","volume":"334","author":"Lee","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2023.154425_bib70","article-title":"Long non-coding RNAs: The modulators of innate and adaptive immune cells","volume":"154295","author":"Lualbi","year":"2022","journal-title":"Pathology-Research and Practice"},{"key":"10.1016\/j.prp.2023.154425_bib71","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10456-006-9038-9","article-title":"Src activation of Stat3 is an independent requirement from NF-\u03baB activation for constitutive IL-8 expression in human pancreatic adenocarcinoma cells","volume":"9","author":"Trevino","year":"2006","journal-title":"Angiogenesis"},{"key":"10.1016\/j.prp.2023.154425_bib72","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1158\/0008-5472.CAN-11-0908","article-title":"STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesisSTAT3 in pancreatic tumorigenesis","volume":"71","author":"Corcoran","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2023.154425_bib73","doi-asserted-by":"crossref","first-page":"107","DOI":"10.14715\/cmb\/2021.67.3.14","article-title":"Serum JAK\/STAT profile is related to the IL expression but not with the outcome in pancreatic adenocarcinoma patients","volume":"67","author":"Petrusel","year":"2021","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.prp.2023.154425_bib74","first-page":"2020","article-title":"High JAK2 protein expression predicts a poor prognosis in patients with resectable pancreatic ductal adenocarcinoma","author":"Song","year":"2020","journal-title":"Dis. Markers"},{"key":"10.1016\/j.prp.2023.154425_bib75","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.3389\/fonc.2020.01539","article-title":"Glutathione S-transferase Mu-3 PRedicts A Better Prognosis and Inhibits Malignant Behavior and Glycolysis in Pancreatic Cancer","volume":"10","author":"Wang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2023.154425_bib76","first-page":"100","article-title":"HIST3H2A is a potential biomarker for pancreatic cancer: a study based on TCGA data","author":"Zhao","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.prp.2023.154425_bib77","first-page":"10","article-title":"Interleukins associated with breast cancer","author":"Fasoulakis","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.prp.2023.154425_bib78","first-page":"9863","article-title":"Significance of IL28RA in diagnosis of early pancreatic cancer and its regulation to pancreatic cancer cells by JAK\/STAT signaling pathway-effects of IL28RA on pancreatic cancer","volume":"23","author":"Wei W","year":"2019","journal-title":"Eur. Rev. Med Pharm. Sci."},{"key":"10.1016\/j.prp.2023.154425_bib79","first-page":"6906","article-title":"MiR-203 regulates JAK-STAT pathway in affecting pancreatic cancer cells proliferation and apoptosis by targeting SOCS3","volume":"23","author":"Lin","year":"2019","journal-title":"Eur. Rev. Med Pharm. Sci."},{"key":"10.1016\/j.prp.2023.154425_bib80","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","article-title":"IL1-Induced JAK\/STAT signaling is antagonized by TGF\u03b2 to Shape CAF heterogeneity in pancreatic ductal adenocarcinomapathway antagonism shapes CAF heterogeneity in PDAC","volume":"9","author":"Biffi","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.prp.2023.154425_bib81","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/s41388-020-01626-z","article-title":"Targeting STAT3 by a small molecule suppresses pancreatic cancer progression","volume":"40","author":"Chen","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2023.154425_bib82","doi-asserted-by":"crossref","first-page":"13023","DOI":"10.2147\/OTT.S278013","article-title":"Progress in understanding the IL-6\/STAT3 pathway in colorectal cancer","volume":"13","author":"Lin","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.prp.2023.154425_bib83","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.3390\/ijms19082299","article-title":"Contribution of STAT3 to inflammatory and fibrotic diseases and prospects for its targeting for treatment","volume":"19","author":"Kasembeli","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2023.154425_bib84","first-page":"217","article-title":"Noncanonical STAT3 activity sustains pathogenic Th17 proliferation and cytokine response to antigen","author":"Poholek","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.prp.2023.154425_bib85","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3389\/fimmu.2020.00348","article-title":"Transcriptional regulators of T helper 17 cell differentiation in health and autoimmune diseases","volume":"11","author":"Capone","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.prp.2023.154425_bib86","first-page":"21","article-title":"Some Trace Elements and Oxidative Stress Status in Patients with Chronic Rheumatoid Arthritis","volume":"2","author":"Abd Alameer","year":"2023","journal-title":"Journal of Biomedicine and Biochemistry"},{"key":"10.1016\/j.prp.2023.154425_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-021-00705-2","article-title":"Coordinated regulation of immune contexture: crosstalk between STAT3 and immune cells during breast cancer progression","volume":"19","author":"Jin","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.prp.2023.154425_bib88","volume":"3","author":"Wang","year":"2022","journal-title":"STAT3 Pathw. Cancer.: , Present, Future MedComm"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823001255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823001255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:56:09Z","timestamp":1759733769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823001255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":88,"alternative-id":["S0344033823001255"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154425","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"STAT3 signaling in pancreatic ductal adenocarcinoma: a candidate therapeutic target","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154425","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154425"}}